GENEVA, (Reuters) – Technical experts at the World Health Organization (WHO) will review on April 26 Chinese drugmaker Sinopharm’s COVID-19 vaccine for possible emergency use listing, to be followed by the Sinovac jab on May 3, the agency said yesterday.
“We would expect a decision a couple of days later,” the WHO said in response to a Reuters query.
So far COVID-19 vaccines made by Pfizer AstraZeneca and Johnson & Johnson have received a WHO listing – an endorsement of their safety and efficacy that helps to guide countries’ regulatory agencies.
